At CPHI China 2025, Leadsynbio presented its full range of products spanning Human Nutrition, Animal Nutrition, and Pharmaceutical Intermediates, together with the latest synthetic biology innovations. Key highlights included Florfenicol, NMN/NAD rawmaterials, and 25-Hydroxy Vitamin D3, all produced through advanced biomanufacturing processes that improve efficiency, reduce costs, and lower carbon emissions. With products already reaching nearly 20 global markets, Leadsynbio has established itselfas a leading supplier of sustainable ingredients. Supported by a robust global R&D and production network, the company is advancing multiple new pipeline products and accelerating international certifications. Looking forward, Leadsynbio is committedto driving original innovation and providing the worldwide market with eco-friendly, cost-effective biomanufacturing solutions.
[ Details ]Recently, the 2025 GBC Global Biomanufacturing Conference was held in Suzhou, China, where the 2025 Biomanufacturing Industry Rankings were officially released. Leveraging its strong capabilities in original R&D, full industry-chain integration, and sustainable growth, Leadsynbio wa......
[ Details ]Recently, the Anhui Provincial Veterinary Drug and Feed Supervision Institute, together with the Department of Animal Husbandry and Veterinary Medicine and the Wuhu Veterinary Management Service Center, conducted an on-site Good Manufacturing Practice (GMP) inspection of Leadsynbio’s w......
[ Details ]25-Hydroxyvitamin D₃ (25-OH-D₃) is gainingincreasing attention in animal nutrition due to its superior absorption andefficacy compared to traditional Vitamin D₃. As synthetic biology advances its production and formulation, itis essential to understand its benefits, applications, and gl......
[ Details ]25-Hydroxyvitamin D₃ (25(OH)D₃) has evolved from a niche feed additive into a globally recognized nutritional ingredient for livestock and poultry. This article explores its industrial development, production technologies, and quality standards, witha focus on biosynthesis through synthetic biology. As innovation in synthetic biology manufacturing advances, 25(OH)D₃ is set to play a pivotal role in sustainable animal nutrition worldwide.
[ Details ]How much NMN is safe—and effective—to take? This article reviews findings from over 13 global clinical trials, including recent RCTs and long-term safety studies. The data show that NMN doses ranging from 250 mg to 900 mg/day are well tolerated acrossdiverse populations. The benefits include NAD⁺ restoration, muscle performance improvement, sleep support, and sustained safety over 8–24 weeks.
[ Details ]A landmark clinical study conducted by Keio University has confirmed that oral supplementation of NMN is sage and well-tolerated in healthy adults at doses up to 500 mg.
[ Details ]This article dives into why25-Hydroxyvitamin D₃ (25-OH D₃)is a superior nutritional solution compared to Vitamin D₃ for animal health and production.
[ Details ]The longevity molecule NMN is shifting to skincare. Backed by growing regulatory approvals, research validates its anti-aging benefits, driving next-gen innovation.
[ Details ]This study investigated the effects of daily 300mg nicotinamide mononucleotide (NMN) supplementation over 8 weeks in 17 healthy postmenopausal women (mean age: 55). Results demonstrated significant improvements across multiple health parameters.
[ Details ]